Завершено
Фаза III
Беларусь
LR769 (рекомбинантный фактор свёртывания крови) · rEVO Biologics Inc.
A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors to Factor VIII or IX